OS Therapies Inc Interest Expense Nonoperating
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-08-14
- OS Therapies Inc interest expense nonoperating for the quarter ending 2026-06-30 was $5.58K.
- OS Therapies Inc interest expense nonoperating for the quarter ending 2026-03-31 was $75.34K.
- OS Therapies Inc interest expense nonoperating for the quarter ending 2024-12-31 was $7.56K, a 97.54% decline year-over-year.
- OS Therapies Inc interest expense nonoperating for the quarter ending 2024-09-30 was $437.84K, a 67.63% decline year-over-year.
- OS Therapies Inc interest expense nonoperating for fiscal 2024 was $2.05M, a 40.51% decline from fiscal 2023.
- OS Therapies Inc interest expense nonoperating for fiscal 2023 was $3.45M.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.58K 10-Q · filed 2026-08-14 | $80.92K 10-Q · filed 2026-08-14 | ||
| 2026-03-31 | $75.34K 10-Q · filed 2026-05-18 | |||
| 2024-12-31 | $7.56K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $445.39K derived: sum of 2 quarters · filed 2026-03-31 | $1.22M derived: sum of 3 quarters · filed 2026-03-31 | $2.05M 10-K · filed 2026-03-31 |
| 2024-09-30 | $437.84K 10-Q · filed 2025-11-14 | $1.22M derived: sum of 2 quarters · filed 2025-11-14 | $2.04M 10-Q · filed 2025-11-14 | $2.35M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $777.68K 10-Q · filed 2025-08-18 | $1.61M 10-Q · filed 2025-08-18 | $1.91M derived: sum of 3 quarters · filed 2025-08-18 | $3.27M derived: sum of 4 quarters · filed 2025-08-18 |
| 2024-03-31 | $828.76K 10-Q · filed 2025-05-15 | $1.14M derived: sum of 2 quarters · filed 2025-05-15 | $2.49M derived: sum of 3 quarters · filed 2025-05-15 | $3.48M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $307.53K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $1.66M derived: sum of 2 quarters · filed 2025-03-31 | $2.65M derived: sum of 3 quarters · filed 2025-03-31 | $3.45M 10-K · filed 2025-03-31 |
| 2023-09-30 | $1.35M 10-Q · filed 2024-11-15 | $2.34M derived: sum of 2 quarters · filed 2024-11-15 | $3.14M 10-Q · filed 2024-11-15 | |
| 2023-06-30 | $989.68K 10-Q · filed 2024-08-14 | $1.79M 10-Q · filed 2024-08-14 |